FDA Approves Eli Lilly Alzheimer's Drug Donanemab
A sign with the company logo stands outside the Eli Lilly and Company headquarters on March 17, 2024 in Indianapolis, Indiana. Scott Olson | Getty Images The Food and Drug…
Biden, Sanders call out Novo Nordisk, Eli Lilly for high drug costs in op-ed
President Biden and Sen. Bernie Sanders (I-Vt.) continued their call for lower drug prices in an op-ed published Tuesday, citing the high cost of weight-loss products made by Novo Nordisk…
Eli Lilly expects that the FDA will soon call on Zepbound for sleep apnea
Eli Lilly said Friday it has applied for U.S. approval for its weight-loss drug Zepbound to treat the most common sleep-related breathing disorder and expects regulators to do so make…
Eli Lilly CFO Anat Ashkenazi on managing rising demand for GLP-1s
A pharmacist has boxes of Eli Lilly & Co brand tirzepatide medications. Mounjaro, arranged at a pharmacy in Provo, Utah, USA, on Monday, November 27, 2023. George Frey | Bloomberg…
Eli Lilly big GLP-1 investment – plus CRM, BBY, FL, COST earnings next week
Every weekday, the CNBC Investing Club with Jim Cramer hosts a livestream “Morning Meeting” at 10:20 a.m. ET. Here's a recap of Friday's biggest moments. 1. Wall Street rose Friday…
FDA advisors recommend Eli Lilly Alzheimer's drug donanemab
Eli Lilly headquarters in Indianapolis, Indiana, USA, on Wednesday, May 3, 2023. Eli Lilly & Co. stock. rose in early U.S. trading after the experimental Alzheimer's drug slowed the disease's…
Eli Lilly invests to increase the offering of Mounjaro and Zepbound
An injection pen containing Eli Lilly's weight-loss drug Zepbound goes on display in New York City on December 11, 2023. Brendan McDermid | Reuters Eli Lilly said Friday it is…
Keysight Technologies, Nordson traps; Eli Lilly, Lam Research Rise, Tuesday 21/05/2024
NEW YORK — Stocks that trade heavily or see significant price changes on Tuesday: AutoZone Inc. (AZO), down $114.04 to $2,810. The auto parts retailer reported fiscal third-quarter revenue that…
Amgen zou de dominantie van Novo Nordisk en Eli Lilly kunnen bedreigen
Het injecteerbare afslankmedicijn Wegovy is op 24 april 2024 verkrijgbaar bij New City Halstead Pharmacy in Chicago, Illinois. Scott Olson | Getty-afbeeldingen Novo Nordisk En Eli Lilly domineren al lange…